NASDAQ
Elevation Oncology, Inc. (ELEV) has a current ratio of 21.21x as of Monday, May 25, 2026. This represents a 51.32% increase compared to its 12-month average of 14.01x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.